Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

High-deductible health plans can offer expanded benefits for contraception, diabetes, and breast cancer services to enrollees ...

Worldwide Medical Devices sales increased 11.7% on a reported basis and 13.3% on an organic basis in the third quarter, ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report) and keeping the price ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

There are many reasons to own Abbott Laboratories (NYSE: ABT), but they all boil down to one thing: consistent market-beating returns.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, ...

Insulin Pumps MarketThe Insulin Pumps Market revenue were estimated at USD 5.5 Billion in 2022 and is anticipated to grow at a CAGR of 10.3% from 2022 to 2032, according to a recently published Future ...

Read more on the importance of stock picking in today's market, with two standout dividend stocks offering strong ...